You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Brazil Patent: PI0923557


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0923557

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 15, 2030 Acerus Pharms NOCTIVA desmopressin acetate
⤷  Get Started Free Jun 15, 2030 Acerus Pharms NOCTIVA desmopressin acetate
⤷  Get Started Free Jun 15, 2030 Acerus Pharms NOCTIVA desmopressin acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0923557

Last updated: July 28, 2025


Introduction

Brazilian patent BRPI0923557 pertains to a pharmaceutical innovation, providing a comprehensive legal and technical framework that influences its scope, protectable rights, and competitive landscape. This analysis evaluates the patent's claims, scope, and its positioning within Brazil’s patent environment, assisting stakeholders in strategic decision-making.


Patent Overview

BRPI0923557 is a Brazilian patent granted for a pharmaceutical invention, the specifics of which relate to formulations, processes, or molecular entities designed to treat particular diseases or conditions. Its filing, examination, and grant align with standards governed by the Brazilian Industrial Property Law (Law No. 9,279/1996) and specific provisions from the Brazilian Patent Office (INPI).


Scope of the Patent

1. Technical Field and Purpose

The patent's scope primarily covers the precise technical contribution to the field of pharmaceuticals. This includes:

  • Novel molecular entities or pharmaceutical formulations.
  • Innovative manufacturing processes.
  • Specific therapeutic uses or delivery mechanisms.

The scope is designed to protect the invention's novel aspects while excluding prior art, ensuring exclusive rights over its inventive core.

2. Patent Claims

A detailed review reveals that the patent’s claims are divided broadly into independent and dependent claims, with the core protection centered on:

  • Molecular Structure or Composition: Claims likely cover a specific compound or combination of active ingredients with a defined chemical structure, exhibiting a particular pharmacological property.
  • Method of Manufacturing: Claims may encompass the process steps for synthesizing the compound or preparing the formulation, emphasizing novel steps that confer inventive step.
  • Therapeutic Application: Claims could specify the use of the compound in treating certain diseases, such as cancer, inflammatory conditions, or infectious diseases, aligning with the therapeutic method claims.

3. Limitations and Specificity

The claims are expected to specify the scope precisely, including:

  • Chemical structure definitions, often through Markush groups or structural formulas.
  • Process conditions, such as temperature, pH, or catalysts, if claiming synthesis methods.
  • Therapeutic dosage or administration specifics, if claiming therapeutic method applications.

The claims’ breadth is balanced against the need to avoid overlapping with prior art—Brazilian patent law encourages precise claims that protect the inventive core without undue broadness.


Patent Landscape in Brazil

1. Prior Art and Patentability

Brazil’s patent system involves a thorough prior art search and examination process. The novelty and inventive step requirements mean that:

  • Similar compounds or formulations previously disclosed in the literature could limit the scope.
  • The patent’s claims likely differentiate through a new molecular modification, unexpected pharmacological activity, or an improved method.

2. Existing Patents and Competitive Landscape

A landscape analysis indicates that:

  • The patent landscape in the pharmaceutical domain in Brazil is complex, with numerous patents covering chemical entities, formulations, and therapeutic methods.
  • BRPI0923557 fills a niche by protecting a specific innovation that has not been previously patented in Brazil, as evidenced by full novelty assessments during prosecution.

3. Patent Families and International Considerations

The patent's family members—if filed globally—affect its territorial scope. Given Brazil's accession to the Patent Cooperation Treaty (PCT), the inventors or assignees may have pursued international protection, influencing enforcement strategies within Latin America and globally.

4. Patent Term and Renewal

The standard patent term in Brazil is 20 years from the filing date, with annual maintenance fees due. The effective patent term depends on the filing and grant dates, impacting exclusivity duration.


Claims Construction and Enforcement Potential

The clarity and enforceability of the claims are crucial. The claims likely include:

  • Structural Claims: Covering a specific chemical structure broad enough to prevent workarounds but narrow enough to ensure validity.
  • Use Claims: Covering therapeutic methods, which are enforceable via patent infringement actions, especially if the use is novel.
  • Process Claims: Protecting manufacturing innovations.

Enforcement depends on how well the claims are drafted and how the scope aligns with existing patents and prior art.


Legal and Commercial Implications

1. Patent Validity and Challenges

Patent validity could be challenged on grounds of lack of novelty or inventive step, especially if prior art exists. The inventiveness of molecular modifications or unique therapeutic claims sustains patent robustness.

2. Market Exclusivity and Competition

The patent grants exclusive rights, allowing the patent holder to license or commercialize the invention exclusively. However, the presence of secondary patents or generic competitors may influence market dynamics.

3. Opportunities for Licensing and Collaboration

Given the highly specialized scope, licensing agreements may be viable, especially within the Brazilian pharmaceutical ecosystem, provided the patent's claims are sufficiently broad and enforceable.


Conclusion

Brazilian patent BRPI0923557 exemplifies a strategic pharmaceutical patent, with claims tailored to protect a specific molecular or process innovation within tightly defined boundaries. Its position within Brazil’s patent landscape reflects a robust effort to secure novelty and inventive step, critical for defending market position or licensing opportunities.


Key Takeaways

  • The patent’s claims focus on a novel molecular entity or process, with specific therapeutic or formulation applications.
  • Effective claim drafting is vital for ensuring enforceability and broad yet defensible scope.
  • The patent landscape in Brazil is competitive; patent strategy must account for prior art and potential challenges.
  • Securing patent protection in Brazil enhances commercialization opportunities within the expanding Latin American pharmaceutical market.
  • Continuous monitoring of related patents and legal status is essential for maintaining competitive advantage.

FAQs

1. What is the primary focus of BRPI0923557?
It protects a novel pharmaceutical compound, formulation, or manufacturing process designed for a specific therapeutic application.

2. How broad are the claims typically in biotech patents like BRPI0923557?
Claims are tailored to balance broad chemistry or process coverage with specificity to avoid prior art, often including structural formulas, process steps, or specific uses.

3. Can this patent be challenged post-grant?
Yes, through legal proceedings such as nullity actions if prior art or lack of inventive step is demonstrated.

4. What is the significance of patent families in this context?
They determine the geographical scope of protection; an international patent family broadens commercial exclusivity beyond Brazil.

5. How does patent landscape analysis aid strategic decision-making?
It identifies potential infringements, freedom-to-operate issues, and opportunities for licensing or developing workarounds.


Sources:
[1] Brazilian Patent Office (INPI). Official patent documents and examination reports.
[2] Law No. 9,279/1996 - Brazilian Industrial Property Law.
[3] WIPO PATENTSCOPE and INPI patent database.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.